Full Description
The Seventh International Barts Symposium was held on April 20, 2001, in London. This monograph summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. The contributors are world-renowned experts in the field, and they provide incisive commentary in their respective specialties. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the future of the glitazones in management. Changing Therapies for Type 2 Diabetes is essential for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.
Contents
The heterogeneity of type 2 diabetes. Preventing cardiovascular disease in diabetes. Insulin by mouth (buccalor inhaled). Long-acting insulin analogue. Potential of glitazones in diabetes. Clinical value of glitazones.
